ENT Support
- Product NDC
- 43742-2358
- 11-digit product format
- 437422358
- Labeler code
- 43742
- Product ID
- 43742-2358_0ee2115f-c0ba-44fe-a39c-dc5a28cb301a
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Argentum Nitricum, Aspergillus Niger, Candida Albicans, Euphorbium Officinarum, Gallicum Acidum, Hepar Sulphuris Calcareum, Influenzinum (2024 - 2025), Luffa Operculata, Mercurius Iodatus Ruber, Mucor Racemosus, Mutabile Bacillus (Bach), Pulsatilla (Pratensis), Sinusitisinum
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Deseret Biologicals, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2026-02-23
- Substance
- ASPERGILLUS NIGER VAR. NIGER; CALCIUM SULFIDE; CANDIDA ALBICANS; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; GALLIC ACID MONOHYDRATE; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE; LUFFA OPERCULATA FRUIT; MERCURIC IODIDE; MUCOR RACEMOSUS; PULSATILLA PRATENSIS WHOLE; SILVER NITRATE; SINUSITISINUM
- Active strength
- 10; 10; 10; 30; 6; 10; 12; 12; 12; 12; 6; 8; 10; 4; 10; 17 [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
- Pharmacologic classes
- Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ENT Support
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ASPERGILLUS NIGER VAR. NIGER | 10 [hp_C]/mL |
| CALCIUM SULFIDE | 10 [hp_X]/mL |
| CANDIDA ALBICANS | 10 [hp_C]/mL |
| ESCHERICHIA COLI | 30 [hp_C]/mL |
| EUPHORBIA RESINIFERA RESIN | 6 [hp_X]/mL |
| GALLIC ACID MONOHYDRATE | 10 [hp_C]/mL |
| INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) | 12 [hp_C]/mL |
| INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) | 12 [hp_C]/mL |
| INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE | 12 [hp_C]/mL |
| INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE | 12 [hp_C]/mL |
| LUFFA OPERCULATA FRUIT | 6 [hp_X]/mL |
| MERCURIC IODIDE | 8 [hp_X]/mL |
| MUCOR RACEMOSUS | 10 [hp_C]/mL |
| PULSATILLA PRATENSIS WHOLE | 4 [hp_X]/mL |
| SILVER NITRATE | 10 [hp_X]/mL |
| SINUSITISINUM | 17 [hp_X]/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9IOA40ANG6, 1MBW07J51Q, 4D7G21HDBC, 514B9K0L10, 1TI1O9028K, 48339473OT, 6TU4EY6UNW, AU5C98U4BB, CYK5P89K8X, PS2DCE2WVF, C4MO6809HU, R03O05RB0P, 17RH99LQ7G, 8E272251DI, 95IT3W8JZE, B575563DM5 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43742-2358-1 | ENT Support | 30 mL in 1 BOTTLE, DROPPER | LIQUID | 30 | | 1 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 43742-2358-1 | 43742235801 | 30 mL in 1 BOTTLE, DROPPER (43742-2358-1) | 30 ml | 2026-02-23 | No | No | Historical |